Nanoporous delivery system to treat osteomyelitis and regenerate bone: Gentamicin release kinetics and bactericidal effect

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 73, Issue 2, 2005, Pages 277-284

  El Ghannam, Ahmed ^a   Ahmed, Karima ^b   Omran, Maha ^c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b CAIRO UNIVERSITY   (Egypt)

^c Assiut Branch   (Egypt)

Author keywords

Bone regeneration; Dead bone tissue; Nanoporous delivery system; Osteomyelitis

Indexed keywords

BONE; FOURIER TRANSFORM INFRARED SPECTROSCOPY; NANOSTRUCTURED MATERIALS; NANOTECHNOLOGY;

BIOLOGICAL APATITE LAYERS; GENTAMICIN; OSTEOMYELITIS;

ANTIBIOTICS;

APATITE; CALCIUM PHOSPHATE; GENTAMICIN BONE CEMENT; SILICON DIOXIDE;

ANTIBIOTIC THERAPY; ARTICLE; BACTERICIDAL ACTIVITY; BODY FLUID; BONE INFECTION; BONE REGENERATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG DELIVERY SYSTEM; INFRARED SPECTROSCOPY; KINETICS; NONHUMAN; OSTEOMYELITIS; POROSITY; SIMULATION; STAPHYLOCOCCUS AUREUS; SURFACE PROPERTY; SUSTAINED DRUG RELEASE; SYSTEMIC THERAPY; WOUND IRRIGATION;

ANTI-BACTERIAL AGENTS; APATITES; BONE REGENERATION; CALCIUM PHOSPHATES; DRUG DELIVERY SYSTEMS; GENTAMICINS; HYDROGEN-ION CONCENTRATION; KINETICS; MATERIALS TESTING; OSTEOMYELITIS; SILICON DIOXIDE; SURFACE PROPERTIES;

EID: 18244394005     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.b.30209     Document Type: Article

References (54)

1. Ostermann PA, Henry SL, Seligson D. The role of local antibiotic therapy in the management of compound fractures. Clin Orthop 1993;295:102-111.
2. Eitemuller J, Schmidt KH, Peters G. Experimental and preliminary experience with absorbable calcium phosphate granules containing antibiotics or antiseptic for the treatment of osteomyelitis. J Hosp Infect 1983;6:177-184.
3. Laurencin CT, Gerhart T, Witschger P, Satcher R, Domb A, Rosenberg AE, Hanff P, Edsberg L, Hayes W, Langer R. Biorodible polyanhydrides for antibiotic drug delivery: In vivo osteomyelitis treatment in a rat model system. J Orthop Res 1993;11:256-262.
4. Baker PL, Smith RA, William RS, Dutkowsky JP. Comparison of antibiotic release from polymethylmethacrylate beads and collagen sponge. Orthop Res 1994;12:737-741.
5. Itokazu M, Aoki T, Nonomura H, Nishimoto Y, Itoh Y. Antibiotic-loaded porous hydroxyapatite blocks for the treatment of osteomyelitis and postoperative infection. A preliminary report. Bull Hosp Joint Dis 1998;57:125-129.
6. Dash AK, Cudworth GC. Therapeutic applications of implantable drug delivery systems. J Pharmacol Toxicol Methods 1998; 40:1-12.
7. Rushton N. Application of local antibiotic therapy. Eur J Surg 1997;578:27-30.
8. Wahing H, Dingeldein E, Bergmann R, Reuss K. The release of gentamicin from polymethylmethacrylate beads: An experimental and pharmacokinetic study. J Bone Joint Surg [Br] 1978;60: 270.
9. Henry SL, Galloway KP. Local antibacterial therapy for the management of orthopedic infections. Pharmacokinetic considerations. Clin Pharmacokinet 1995;29:36-45.
10. Nelson CL, Hickmon SG, Harrison H. Elution characteristics of gentamicin-PMMA beads after implantation in humans. Orthopedics 1992;17:415-416.
11. Şerbetçi K, Korkusuz F, Hasirci N. Mechanical and thermal properties of hydroxyapatite-impregnated bone cement. Turk J Med Sci 2000;30:543-549.
12. Leong KW, Brott BC, Ranger R. Bioerodible polyanhidrides as drug-carrier matrices. I: Characterization, degradation, and release characteristics. J Biomed Mater Res 1985;19:941-945.
13. Gombotz W, Pankey SC, Bouchard LS, Phan DH, Poulallainen PA. Simulation of bone healing by transforming growth factor-beta, released from polymers or ceramic implants. J Appl Biomater 1994;5:141-150.
14. Agrawal CM, Kennedy ME, Micallef DM. The effect of ultrasound irradiation on a degradable 50-50% copolymer of polylactic and polyglycolic acids. J Biomed Mater Res 1994;28: 851-859.
15. Hench L, Willson J, editors. An introduction to bioceramics. Singapore: World Scientific; 1993. pp 41-62.
16. Gao TJ, Lindholm TS, Kommonen B, Ragni P, Paronzini A, Landholm TC. Microscopic evaluation of bone-implant contact between hydroxyapatite, bioactive glass, and tricalcium phosphate implanted in sheep diaphyseal defects. Biomaterials 1995; 16:1175-1179.
17. Ślósarczyk A, Szymura-Oleksiak J, Mycek B. The kinetics of pentoxifylline release from drug-loaded hydroxyapatite implants. Biomaterials 2000;21:1215-1221.
18. Akashi A, Matsuya Y, Unemori M, Akamine A. Release profile of antimicrobial agents from α-tricalcium phosphate cement. Biomaterials 2001;22:2713-2717.
19. Martins C, Goissis A. Nonstichometric hydroxyapatite-anionic collagen composite as support for the double sustained release of gentamicin and norfloxacin/ciprofloxacin. Artif Organs 2000; 24:224-230.
20. Ragel CV, Vallet-Regi M. In vitro bioactivity and gentamicin release from glass-polymer-antibiotic composites. J Biomed Mater Res 2000;51:424-429.
21. Yamamura K, Iwata H, Yotsuyanagi T. Synthesis of antibiotic-loaded hydroxyapatite beads and in vitro drug release testing. J Biomed Mater Res 1992;26:1053-1064.
22. Shinto Y, Uchida A, Korkusuz F, Araki N, Ono K. Calcium hydroxyapatite ceramic used as a delivery system for antibiotics. J Bone Joint Surg 1992;74B:600-604.
23. Korkusuz F, Uchida A, Shinto Y, Araki N, Inoue K, Ono K. Experimental implant-related osteomyelitis treated by antibiotic-calcium hydroxyapatite ceramic composites. J Bone Joint Surg [Br] 1993;75:111-114.
24. Itokazu M, Matsunaga T, Kumazawa S, Yang W. A novel drug delivery system for osteomyelitis using porous hydroxyapatite blocks loaded by centrifugation. J Appl Biomater 1995;6:167-169.
25. Otsuka M, Matsuda Y, Kokubo K, Yoshihara S, Nakamura T, Yamamura T. Drug release from a novel self-setting bioactive glass bone cement containing cephalexin and its physicochemical properties. J Biomed Mater Res 1995;29:33-38.
26. Pham HH, Luo P, Génin F, Dash AK. Synthesis and characterization of hydroxyapatite-ciprofloxacin delivery systems by precipitation and spray drying technique. AAPS Pharm Sci Tech 2002;3:1-9.
27. Kimakhe S, Bohic S, Larrose C, Reynaud A, Pilet P, Daculsi G. Biological activities of sustained polymyxin B release from calcium phosphate biomaterial prepared by dynamic compaction: An in vitro study. J Biomed Mater Res 1999;47:18-27.
28. Gautier H, Daculsi G, Merle C. Association of vancomycin and calcium phosphate by dynamic compaction: in vitro characterization and microbiological activity. Biomaterials 2001;22:2481-2487.
29. Radin S, Campbell JT, Ducheyne P, Cuckler JM. Calcium phosphate ceramic coatings as carrier of vancomycin. Biomaterials 1997;18:777-782.
30. Campbell AA, Song L, Li XS, Nelson BJ, Brooks DE, Dejong ES. Development, characterization, and anti-bacterial efficacy of hydroxyapatite-chlorhexidine coatings produced by surface-induced mineralization. J Biomd Mater Res 2000;53:400-407.
31. Trécant M, Guicheux J, Grimandi G, Leroy M, Daculsi G. Dynamic compaction: A new process to compact therapeutic agent-loaded calcium phosphates. Biomaterials 1997;18:141-145.
32. Gautier H, Merle C, Auget JL, Daculsi G. Isostatic compression, a new process for incorporating vancomycin into biphasic calcium phosphate: Comparison with a classical method. Biomaterials 2000;21:243-249.
33. Gautier H, Caillon J, LeRay AM, Dacusli G, Merle C. Influence of isostatic compression on the stability of vancomycin loaded with calcium phosphate-implantable drug delivery device. J Biomed Mater Res 2000;52:308-314.
34. Arcos D, Ragel CV, Vallet-Regí M. Bioactivity in glass/PMMA composites used as drug delivery system. Biomaterials 2001; 22:701-788.
35. Santos EM, Radin S, Ducheyne P. Sol-gel derived carrier for controlled release of proteins. Biomaterials 1999;20:1695-1700.
36. Radin S, Ducheyne P, Kamplain T, Tan BH. Silica sol-gel for the controlled release of antibiotics. I. Synthesis, characterization, and in vitro release. J Biomed Mater Res 2001;57:313-320.
37. Ducheyne P, Radin S, Santos E. US Patent Number 5,591,453 (1997).
38. Thut PD, Litkowski Leonard J, Greenspan, David C. US Patent Number 6,197,342 (2001).
39. El-Ghannam A. Advanced bioceramic composite for bone tissue engineering: Design principles and structure-bioactivity relationship. J Biomed Mater Res 2004;69A:490-501.
40. Wachol-Drewek Z, Pfeiffer M, Scholl E. Comparative investigation of drug delivery of collagen implants saturated in antibiotic solutions and a sponge containing gentamicin. Biomaterials 1996;17:1733-1738.
41. Yaylaoǧlu MB, Korkusuz P, Örs Ü, Korkusuz F, Hasirci V. Development of a calcium phosphate-gelatin composite as a bone substitute and its use in drug release. Biomaterials 1999; 20:711-719.
42. Wichelhaus TA, Dingeldein E, Rauschmann M, Kluge S, Dieterich R, Schäfer V, Brade V. Elution characteristics of vancomycin, teicoplanin, gentamicin and clindamycin from calcium sulphate beads. J Antimicrob Chemother 2001;48:117-119.
43. Winkler H, Janata O, Berger C, Wein W, Georgopoulos A. In vitro release of vancomycin and tobromycin from impregnated human and bovine bone grafts. J Antimicrobal Chemother 2000; 46:423-428.
44. Kokubo T, Kushitani H, Sakka S. Solutions able to reproduce in vivo surface-structure changes in bioactive glass-ceramic A-W. J Biomed Mater Res 1990;24:721-734.
45. Kangasniemi IMO, de Groot K, Becht JGM, Yli-Urpo A. Preparation of dense hydroxyapatite or rhenanite containing bioactive glass composite. J Biomed Mater Res 1992;26:663-674.
46. Ramselaar MMA, Driessens FCM, Kalk W, de Wijn IR, van Mullem PI. Biodegradation of four calcium phosphate ceramics; in vivo rates and tissue interactions. J Mater Sci Mater Med 1991;2:63-70.
47. White DJ, Gerlach RW. Anticalculus effects of a novel, dualphase polypyrophosphate dentifrice: Chemical basis, mechanism, and clinical response. J Contemp Dent Pract 2000;1(4): 001-019.
48. Lacefield WR. Materials characteristics of uncoated/ceramic-coated implant materials. Adv Dent Res 1999;13:24.
49. Li P, Ohtsuki C, Kokubo T, Nakanishi K, Soga N, Nakamura T, Yamamuro T. Process of formation of bone-like apatite layer on silica gel. J Mater Sci Mater Med 1993;4:127-131.
50. Miyaji F, Iwai M, Kokubo T, Nakamura T. Chemical surface treatment of silicone for inducing its bioactivity. London: Chapman & Hall; 1998. pp 61-65.
51. 2 substrates in vitro. J Biomed Mater Res 1999;44:12-21.
52. Pereira MM, Clark AE, Hench LL. Effect of texture on the rate of hydroxyapatite formation on gel-silica surface. J Am Ceram Soc 1995;78:2463-2468.
53. Hamanishi C, Kitamoto K, Tanaka S, Otsuka M, Doi Y, Kitahashi T. A self-setting TTCP-DCPD apatite cement for release of vancomycin. J Biomed Mater Res B: Appl Biomater 1996; 33:139-143.
54. Horcjada P, Rámila A, Pérez-Paeiente J, Vallet-Regí M. Influence of pore size of MCM-41 matrices on drug delivery rate. Microporous Mesoporous Mater 2004;68:105-109.